In 2012, C.M. Nijenhuis and a team from University of Groningen (Groningen, The Netherlands) published a study titled “Disturbed development of the enteric nervous system after in utero exposure of selective serotonin re-uptake inhibitors and tricyclic antidepressants. Part 1:
Justinian Lane
Justinian Lane is a legal publisher specializing in asbestos and mesothelioma claims, operated as a division of Justinian C. Lane, Esq. – PLLC. The organization provides detailed information on asbestos litigation, related diseases, and compensation claims, including guidance on filing asbestos claims and understanding asbestos trusts. Their content covers various sources of asbestos exposure, symptoms, treatments, and legal history. The publisher also addresses related legal areas such as workers' compensation, veterans disability claims, and maritime claims. Justinian Lane maintains a database of asbestos trusts and offers resources for affected individuals seeking legal assistance and compensation.
Latest from Justinian Lane - Page 3
2009 – Preterm birth again linked to SSRI exposure before birth
By Jared Fink
Recently, I found an article titled “Risk of preterm delivery and other adverse perinatal outcomes in relation to maternal use of psychotropic medications during pregnancy.” that originally appeared in the December 2009 edition of American Journal of Obstetrics…
Risk for birth defects 47% higher with prenatal exposure to Depacon, Depakene, or Depakote
By Jared Fink
In January of last year, a team of researchers led by E. Campbell published an article in Epilepsia titled “Recurrence risk of congenital malformations in infants exposed to antiepileptic drugs in utero.”, marking yet another piece of professional…
Study shows: Depacon lifts risk for autism 300%
By Jared Fink
Today, I found another article by G. Veiby and a team from The University of Bergen in Bergen, Norway that demonstrates the danger posed to children exposed to valproate in utero. Valproate (sodium valproate, other formations) is the active…
2011 – Birth defect risk “significantly higher” with Depacon, Depakene, or Depakote exposure before birth
By Jared Fink
In July, 2011, Lancet Neurology published an article titled “Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry.” that was written by a team from Stockholm led by T.…
SSRIs in pregnancy linked to 12-fold increased risk for preterm birth
By Jared Fink
Today, I came across an article published in a 2011 edition of Journal of Midwifery and Women’s Health by G. Latendresse and a team of researchers from The University of Utah College of Nursing (Salt Lake City) titled “Maternal…
2011 – Low gestational age linked to SSRI exposure, not maternal depression
By Jared Fink
Titled “Newborn neurobehavioral patterns are differentially related to prenatal maternal major depressive disorder and serotonin reuptake inhibitor treatment.”, an article by A.L. Salisbury and a team from the Warren Alpert Medical School of Brown University, appearing in the…
Neurological function adversely affected by maternal SSRIs
By Jared Fink
In May, 2013, N.K. de Vries published an article titled “Early neurological outcome of young infants exposed to selective serotonin reuptake inhibitors during pregnancy: results from the observational SMOK study.” in the medical journal PLoS One. This Dutch…
2011 – Heart development affected by maternal SSRI use
By Jared Fink
Published in the July, 2011 edition of Pediatric Research, a study by D. Rurak and a team from The University of British Columbia (Vancouver) titled “Third trimester fetal heart rate and Doppler middle cerebral artery blood flow velocity characteristics…
Study shows SSRIs affect fetal neurodevelopment
By Jared Fink
From The Netherlands, a team of medical researchers led by E.J. Mulder published a study titled “Selective serotonin reuptake inhibitors affect neurobehavioral development in the human fetus.” in the September, 2011 edition of Neuropsychopharmacology examining the relationship between…